Skip to main content
BoF Logo

Agenda-setting intelligence, analysis and advice for the global fashion community.

Novo Nordisk Launches Wegovy Weight-Loss Pill in US, Triggering Price War

The first and only GLP-1 pill on the market costs significantly less than injectable versions.
Novo Nordisk HQ.
Novo Nordisk’s share price rose by more than 4 percent on Monday, but is still down by 44 percent over the past year amid fierce competition from rivals. (Shutterstock)

The first pill version of the blockbuster GLP-1 weight loss drugs has been launched in the US by

Please sign in to ensure you can read our agenda-setting intelligence, analysis and advice. Or get in touch at support@businessoffashion.com if you experience difficulties.

© 2026 The Business of Fashion. All rights reserved. For more information read our Terms & Conditions

More from Beauty
Analysis and advice on the fast-evolving beauty business.

Can Mikayla Nogueira Sell Fragrance, Too?

The beauty influencer is hoping her 20 million-strong following can cut through the category’s oversaturation with Only Sunshine, a tropical scent launched with indie brand Snif.


Ulta Beauty Joins TikTok Shop

Ulta Beauty becomes the first US specialty beauty retailer to launch on TikTok Shop, making the case for partnership rather than competition with the platform’s beauty e-commerce business.


view more
Latest News & Analysis
Unrivalled, world class journalism across fashion, luxury and beauty industries.

Who Won Fashion’s Red Carpet Season of Change

Sunday night’s Oscars concluded an awards season that fashion’s biggest labels used to show off their new creative game. BoF breaks down what we learned about brands’ celebrity strategies.


VIEW MORE
Agenda-setting intelligence, analysis and advice for the global fashion community.
CONNECT WITH US ON